首页> 外文OA文献 >Tadalafil 5 mg once daily for the treatment of Asian men with lower urinary tract symptoms secondary to benign prostatic hyperplasia: Analyses of data pooled from three randomized, double-blind, placebo-controlled studies

【2h】

Tadalafil 5 mg once daily for the treatment of Asian men with lower urinary tract symptoms secondary to benign prostatic hyperplasia: Analyses of data pooled from three randomized, double-blind, placebo-controlled studies

机译：塔达拉非5毫克每天一次治疗亚洲男性患有较低的尿路症状继发于良性前列腺增生：分析来自三个随机，双盲，安慰剂对照研究的数据

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Osamu Nishizawa; Masaki Yoshida; Masayuki Takeda; Osamu Yokoyama; Yoji Morisaki; Masahiro Murakami; Lars Viktrup;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Re: Efficacy and Safety of Tadalafil 5 mg Once Daily in the Treatment of Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia in Men Aged ≥75 Years: Integrated Analyses of Pooled Data from Multinational, Randomized, Placebo-Controlled Clinical Studies [J] . Tomas L. Griebling The Journal of Urology . 2018,第4期

机译：Re：塔达拉非5毫克的疗效和安全性每天一次治疗≥75岁的男性良性前列腺增生治疗症状：跨国，随机，安慰剂对照临床研究的汇总数据综合分析
2. Efficacy and safety of tadalafil 5 mg once daily in the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia in men aged >= 75 years: integrated analyses of pooled data from multinational, randomized, placebo-controlled clinical studies [J] . Oelke Matthias, Wagg Adrian, Takita Yasushi, BJU international . 2017,第5期

机译：塔达拉非5毫克每天一次治疗与良性前列腺增生治疗患者的疗效和安全性> = 75年：跨国，随机，安慰剂对照临床研究的汇总数据综合分析
3. Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia and on erectile dysfunction in sexually active men with both conditions: Analyses of pooled data from four randomized, placebo-controlled tadalafil clinical studies [J] . PorstH., RoehrbornC.G., SecrestR.J., The journal of sexual medicine . 2013,第8期

机译：他达拉非对两种情况下性活跃男性继发于良性前列腺增生的下尿路症状和勃起功能障碍的影响：来自四项随机，安慰剂对照的他达拉非临床研究的汇总数据分析
4. Analysis of glycoforms of urinary prostate-specific antigen of prostate cancer and benign prostate hyperplasia samples [C] . Chun-Jen Hsiao, Tzong-Shin Tzai, Chein-Hung Chen, ASMS Conference on Mass Spectrometry and Allied Topics . 2015

机译：前列腺癌和良性前列腺增生样品的尿道前列腺特异性抗原糖族分析
5. The long-term cost-effectiveness of treatments for benign prostatic hyperplasia. [D] . DiSantostefano, Rachael Lynn. 2005

机译：良性前列腺增生治疗的长期成本效益。
6. Tadalafil vs. tamsulosin in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a prospective randomized study [O] . Vedamurthy Reddy Pogula, Lalith Sagar Kadiyala, Vijayabhaskar Reddy Gouru, 2019

机译：他达拉非与坦索罗辛治疗前列腺增生所致的下尿路症状：一项前瞻性随机研究
7. Impact of Baseline Total Testosterone Level on Successful Treatment of Sexual Dysfunction in Men Taking Once-Daily Tadalafil 5 mg for Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia: An Integrated Analysis of Three Randomized Controlled Trials [O] . John P. Mulhall, Gerald B. Brock, Sidney Glina, 2016

机译：基线总睾酮水平对男性的性功能障碍成功治疗的影响，服用一次性达拉非5毫克为尿路症状和良性前列腺增生：三种随机对照试验的综合分析

Tadalafil 5 mg once daily for the treatment of Asian men with lower urinary tract symptoms secondary to benign prostatic hyperplasia: Analyses of data pooled from three randomized, double-blind, placebo-controlled studies

著录项

相似文献

相关主题

期刊订阅